Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06456255

Bupivacaine and Epinephrine Injection Study

Bupivacaine With Epinephrine vs Sham Injections During Endoscopic Sinus Surgery: a Double Blind, Randomized Controlled Trial

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Amin Javer · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Endoscopic sinus surgery (ESS) is a common otolaryngologic procedure that aims to remove the partitions that separate the sinus cavities, remove inflamed tissue, and optimize the sinuses for topical medication use. In this procedure, the surgeon will inject a combination of drugs, local anesthetics, and vasoconstrictors, to reduce bleeding and improve visualization. However, previous studies have shown similar results when injected with only saline. In this study, investigators want to determine if the injection of local anesthesic+vasoconstrictor compared to no injection at all makes any difference in improving the surgeon's visualization during an ESS.

Conditions

Interventions

TypeNameDescription
DRUGSensorcaine with EpinephrineThe combination contains 0.25% bupivacaine hydrochloride (2.5 mg/mL) and epinephrine bitartrate \[(1:200,000) 5 mcg/mL\] per vial.
OTHERSham injectionPunctures without any medication injected onto the septum

Timeline

Start date
2024-11-15
Primary completion
2025-05-01
Completion
2025-07-01
First posted
2024-06-13
Last updated
2025-05-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06456255. Inclusion in this directory is not an endorsement.